The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Plans make changes to benefits and costs, and there are also many new changes for the 2026 plan year.
MAPRx encourages both new and existing beneficiaries to use this time period to... Read more
The MAPRx Coalition submitted comments to CMS urging that as the MDPNP is implemented, it is imperative that the program is informed by the experiences and needs of beneficiaries living with
chronic diseases and conditions. Read for more.
MAPRx strongly supports CMS’ proposal to permit coverage of anti-obesity medications to treat obesity for appropriate indications. AOMs are a critical component of the continuum of obesity care. Read our Comment Letter
... Read moreMAPx appreciates the opportunity to comment on specific provisions in the CY 2026 policy and technical changes to MA and Part D. Read the Comment Letter
... Read moreThe IRA enacted the most significant changes to Part D since its inception, and these reforms have major implications for Medicare beneficiaries. In this new paper, the MAPRx Coalition examines the potential impact of three of IRA's major Part D provisions.
Read more: Hope for the best, prepare for the worst: The... Read more
The MAPRx Coalition (MAPRx) appreciates the opportunity to provide the Centers for Medicare & Medicaid Services (CMS) with comments regarding the new model documents for the implementation of the Medicare Prescription Payment Plan (MPPP) program set to take effect for Contract Year (CY) 2025.
... Read moreWe are eager to hear about your experiences with the Medicare prescription drug program. We would like to hear about both good and bad experiences that you have had selecting and signing up for a plan, getting your drugs, and paying for your drugs. The form below will allow you to write your story.
Thank you for taking the time to tell us your story.